RankingsPricing
  1. US-listed companies
  2. Qualigen Therapeutics, Inc.

Qualigen Therapeutics, Inc.QLGN

Market cap
$920.16K
P/E ratio
Back to summarized table
Income statementBalance sheetCash flow
Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2021		Dec 31,
2022
Cash-----187
Accounts receivable, net-----822,351538,587
Inventory, net-----12
Prepaid expenses and other current assets----509,51912
Total current assets167231522111
Restricted cash------5,690
Right-of-use assets----93,03221
Property and equipment, net20,68823,54223,87320,16015,656203,920345,087
Intangible assets, net-----171,1906
Goodwill------625,602
Other assets10,32610,32610,32622,725478,07518,33418,334
Total Assets167231532319
Accounts payable739,3572251886,224857,311
Accrued vacation------467,948
Accrued expenses and other current liabilities------2
R&D grant liability------780,682
Deferred revenue, current portion-----135,063116,161
Operating lease liability, current portion----100,471134,091240,645
Short term debt - related party------950,722
Warrant liabilities-----2788,100
Warrant liabilities - related party------3
Convertible debt - related party------60,197
Total current liabilities1336259
Operating lease liability, net of current portion-----21
Deferred revenue, net of current portion-----92,92849,056
Deferred tax liability------357,757
Total liabilities-----610
Common stock, $0.001 par value; 225,000,000 shares authorized; 4,210,737 and 3,529,018 shares issued and outstanding as of December 31, 2022 and December 31, 2021, respectively8,58211,61949,4076,03719,10835,29042,110
Additional paid-in capital4250687280101111
Accumulated other comprehensive income----923--50,721
Accumulated deficit-27,082,942-45,467,576-53,331,434-70,200,145-80,333,164-84,744,629-103
Total Qualigen Therapeutics, Inc. stockholders’ equity1542091179
Noncontrolling interest------2
Total Stockholders’ Equity------9
Total Liabilities & Stockholders’ Equity167231532319